Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
331.53M | 445.58M | 424.55M | 398.63M | 363.85M | Gross Profit |
219.88M | 296.68M | 280.63M | 268.61M | 242.94M | EBIT |
61.64M | 67.11M | 46.94M | 77.36M | 67.79M | EBITDA |
82.57M | 90.36M | 67.70M | 103.40M | 96.05M | Net Income Common Stockholders |
73.49M | 18.50M | 12.29M | 46.49M | 37.42M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
108.50M | 24.11M | 34.93M | 61.04M | 66.18M | Total Assets |
346.29M | 354.88M | 377.79M | 446.97M | 457.00M | Total Debt |
73.94M | 116.81M | 142.95M | 140.90M | 161.95M | Net Debt |
-34.56M | 92.70M | 108.03M | 79.86M | 95.77M | Total Liabilities |
198.84M | 236.58M | 263.10M | 267.29M | 281.83M | Stockholders Equity |
122.02M | 85.99M | 79.13M | 134.08M | 127.53M |
Cash Flow | Free Cash Flow | |||
76.22M | 56.66M | 50.30M | 67.22M | 79.57M | Operating Cash Flow |
83.28M | 72.71M | 57.01M | 75.64M | 87.09M | Investing Cash Flow |
85.42M | -13.67M | -5.78M | -8.69M | 18.31M | Financing Cash Flow |
-84.26M | -69.83M | -77.35M | -72.06M | -71.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | C$208.29M | 3.91 | 36.75% | 0.41% | 19.21% | 105.30% | |
78 Outperform | C$1.88B | 10.76 | 26.88% | 10.16% | 3.67% | -6.05% | |
74 Outperform | C$1.09B | 14.56 | 70.86% | 3.71% | 12.36% | 123.26% | |
71 Outperform | $380.31M | 2.71 | 23.77% | 2.23% | -24.96% | 549.36% | |
71 Outperform | C$59.77M | 11.94 | 19.57% | ― | 38.28% | ― | |
61 Neutral | C$1.53B | 32.98 | 8.99% | 5.60% | 13.72% | 429.22% | |
48 Neutral | $6.86B | 1.11 | -50.22% | 2.47% | 16.71% | 1.53% |
Medical Facilities Corporation has announced a cash dividend of Cdn $0.09 per common share, payable on April 15, 2025, to shareholders of record as of March 31, 2025. This announcement reflects the company’s ongoing commitment to providing shareholder value and may influence investor perceptions positively, reinforcing its stable financial health and strategic positioning in the healthcare industry.
Medical Facilities Corporation reported its financial results for the fourth quarter and full year 2024, highlighting a strong year marked by the sale of Black Hills Surgical Hospital, which bolstered its financial position. The company ended the year with a cash position of $108.5 million, repurchased shares worth $16.6 million, and fully repaid its corporate credit facility. Despite a slight decline in surgical case volumes due to an industry-wide shortage of intravenous saline fluids, the company achieved growth in income from operations and adjusted EBITDA. The sale of BHSH significantly enhanced the company’s ability to return capital to shareholders and focus on operational excellence and quality care.
Medical Facilities Corporation announced the completion of a substantial issuer bid, repurchasing approximately 14.7% of its outstanding common shares for cancellation at a total cost of around $60.7 million. This move is expected to reduce the number of issued and outstanding shares to approximately 19.5 million, potentially enhancing shareholder value and impacting the company’s market positioning. The corporation’s normal course issuer bid, which was suspended during the offer period, will resume shortly, allowing for continued share repurchases until November 2025.
Medical Facilities Corporation announced changes to its Board of Directors, appointing Peter Brimm and Jeremy Klaperman while Yanick Blanchard resigned. The Board will consist of five directors after the next AGM, with Brimm and Klaperman joining the Audit Committee, and Klaperman replacing Blanchard as Chair. These changes are part of a strategic refresh to enhance financial expertise and leadership as the company continues to execute its strategy.
Medical Facilities Corporation has announced an amendment to its substantial issuer bid, increasing the price range for purchasing its common shares from shareholders. The new price range is set between $16.50 and $18.00 per share, representing a significant premium over previous valuations. The offer, which aims to repurchase up to 21.3% of the company’s outstanding shares, has been extended to March 11, 2025. This move is part of the company’s strategy to return capital to shareholders, with any unused funds from the offer to be distributed as a special dividend. Shareholders who previously tendered their shares must retender them to participate under the new terms.
Medical Facilities Corporation is set to announce its fourth-quarter and full-year 2024 financial results on March 13, 2025, with an earnings call scheduled the same morning. The announcement may impact stakeholders by providing insights into the company’s financial health and strategic direction, which could influence its positioning within the healthcare industry.
Medical Facilities Corporation has announced that the Ontario Securities Commission has granted an order allowing the company to extend its substantial issuer bid without needing to first take up any common shares previously deposited. While the company has not yet decided to extend the offer, the current expiration remains set for February 24, 2025. The decision has potential implications for shareholder engagement and corporate operations, as it provides flexibility in their strategic financial maneuvers.
Medical Facilities Corporation announced a substantial issuer bid to purchase and cancel up to $80,750,000 of its common shares. This decision follows the sale of Black Hills Surgical Hospital, with proceeds being used for the offer, reflecting the Board’s view that this move aligns with the company’s strategy to return capital to shareholders. The offer, structured as a modified Dutch auction, allows shareholders to tender shares within a specified price range or at a determined purchase price, ensuring the company retains sufficient resources for ongoing operations.